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The correct perfusion of the myocardium, the heart’s muscle, is a key parameter that has been 
proven to be a powerful tool for the diagnosis of cardiovascular diseases. In general, perfusion 
is defined as the delivery of oxygen and nutrients by the circulatory system to any tissue or 
organ. When an organ like the heart receives insufficient blood supply, an ischemic disease is 
likely to take place.  
 
So far, several image techniques have been used for the study of myocardial perfusion such as 
CT, PET, SPECT or MRI. Due to its high spatial resolution and the avoidance of limitations offered 
by ionizing radiation the following project specifically addresses the MRI technique. The use of 
MRI as diagnostic readouts in patients suffering from cardiovascular diseases is currently 
growing in the clinics. Therefore, having this protocol optimize in a research lab will be of great 
interest 
 
This work was carried out using a 7 Tesla MRI scanner. This scanner is made for preclinical 
research with small animal models which is the first step performed in every research project 
before it can be translated into humans. For the study of perfusion in MRI a contrast agent 
(commonly gadolinium-based) must be intravenously administered to the patient. However, this 
approach offers many drawbacks regarding secondary effects with gadolinium posing health risk 
in patients. 
 
In this context, this project investigates the possibility of avoiding such contrast agent by using 
intrinsic blood oxygenation level instead. This idea relies on the Blood Oxygenated Level 
Dependent (BOLD) principle that describes the magnetic characteristics of oxyhemoglobin and 
deoxyhemoglobin. To this end, the first step was the implementation of a first-pass perfusion in 
rat’s myocardium using gadolinium as contrast agent. The change produced by the passage of 
the gadolinium bolus can be screen with T1 weighted images. A Graphic User Interface was 
developed using MATLAB so as to easily asses the results and furtherly compared both contrast 
agents.  
 
The paramagnetic characteristics of deoxyhemoglobin locally alters the main magnetic field of 
the MRI scanner if its concentration is increased. For this purpose, a gas mixer with two different 
mixtures, one with 100% Oxygen and the other with 100% Nitrogen, was used so as to produce 
changes in the fractions of inspired oxygen (FiO2). Therefore, this method studies the 
relationship between the MRI signal created by the deoxyhemoglobin bolus and the changes of 
FiO2 recorded by a pulse-oximeter. 
 
After several MRI sequence adjustments, the scanner was capable of recording the signal 
produced by the deoxyhemoglobin bolus. Even though the gadolinium signal is more precise 
and accurate, our new proposal is clearly a focal point for further research since it overcomes 
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1. Introduction and theoretical framework 
 
1.1 Medical Imaging 
 
Medical Imaging is the term that refers to different technologies or techniques 
(referred to as ‘modalities’) employed to create representations (acquire, process 
and display) of the interior of the human body in order to assist diagnosis or 
therapeutic procedures [1]. In the last decades special efforts have been made on 
the field by engineers or scientist towards the idea of diagnosing or treating patients 
avoiding side effects or surgical interventions.   
 
The most widespread modalities regarding diagnosis are: Radiography (X-ray), CT 
(Computed Tomography), Nuclear Medicine, Ultrasound or MRI (Magnetic 
Resonance Imaging). Among these, the first three make use of ionizing radiation 
providing enough energy that can remove electrons from the orbit of an atom, 
therefore, making the atom be ionized or charged [2]. This type of radiation can be 
harmful and cause damage to tissues depending on the amount of radiation that is 
absorbed, measured in Gray (Gy).  
 
X-ray imaging is the most ancient one and is based on the physical principles of 
electromagnetic radiation. A beam of X-rays is projected towards the target and 
depending on the object´s density part of the radiation is absorbed. The denser 
tissues would absorb more X-rays photons, such as bone. The remaining radiation is 
captured by the detector and a 2D image is created [3]. Likewise, Computed 
Tomography uses X-ray beams and several detectors that take measurements on 
different angles so as to create tomographic images or “slices” of the area under 
study. The third modality using ionizing radiation is Nuclear Medicine. This 
technique makes use of radioactively labeled substances, such as 18F-
Fluordeoxyglucose (FDG), that are introduced in the body either by injection, 
swallowing or inhalation [4]. After the radiotracer has been introduced, it moves and 
travels through the body while releasing energy in the form of gamma-rays which 
are detected by a detector (gamma cameras). In this case, the radiation is being 
emitted from within the body and not created externally (unlike in CT or 
radiography), therefore, this diagnostic analysis let us study physiological functions 
rather than anatomical structures.  
 
Other techniques that do not make use of ionizing radiation are considered “safe” 
for imaging sensitive patient groups such as pregnant women or children. 
Ultrasound imaging uses high frequency sound waves (20 kHz or higher) whose 
echoes are registered to create real-time images of different tissues and organs. 
Nowadays it is mainly used for different vascular diseases, visualization of muscles 
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or tendons, tumors or fetal monitoring. Finally, Magnetic Resonance Imaging (MRI) 
uses strong magnetic fields and radiofrequency energy creating the perfect 
combination for the study of soft tissue in any part of the human body. It can be 
used for the study of either structural anatomy or physiological processes thanks to 
all the parameters that can be set and modified. As stated before, it does not make 
use of ionizing radiation, it is non-invasive, safe, painless and the final image created 
by the scanner has good spatial resolution and contrast. On the contrary, the usage 
of strong magnets prevents the use of metals nearby the machine, therefore 
excluding any patient wearing prostheses made out of such material. Moreover, the 
acquisition tends to take longer time than other modalities and the scanner produce 
a loud noise that can be unpleasant for the patient. All in all, this technique has 
become one of the most versatile modalities used in many hospitals. To be able to 
understand how MRI works, some concepts regarding electromagnetism had to be 
explained and this would lead us to understand the wide scope of possibilities 
offered by this technique.   
 
1.2 Magnetic Resonance Imaging 
 
1.2.1 The NMR phenomenon: Spin, Precession, Resonance, Excitation and 
Relaxation, Acquisition Parameters, Typical Sequences 
 
The Nuclear Magnetic Resonance (NMR) is a physical phenomenon explained by two 
models: the classical model and the quantum mechanical model (less intuitive)[5]. 
However, for our purposes in most part we will make use of the classical model to 




Every object that rotates has a property known as angular momentum that depends on 
mass, size, shape or velocity. The analogous term for atomic or subatomic particles is 
known as spin, which interacts with electromagnetic fields the same way angular 
momentum interacts with gravitational fields. In contrast to angular momentum, spin 
only takes discrete integer or half-integer units[6]. Nuclear spin values are from 0 to 8, 
and the electron, neutron and proton spin values are always ½. Thus, NMR depends on 
the interaction between a magnetic field and a nucleus with a non-zero nuclear spin. 
Some of the best candidates for the production of NMR signals are: 1H, 3He, 13C, 17O, 19F, 
23Na and 31P. Since Hydrogen is the most abundant (located in water molecules and fat) 
and has the largest magnetic moment, it is the most common nucleus used for NMR 
signal production [4]. As the hydrogen nucleus is composed by a single proton, the 
words spin, nucleus and protons are usually used as synonyms in the magnetic 






The same way a spinning top precesses around a gravitational field, nuclei precess 
around a magnetic field. They both have the tendency of maintaining this motion unless 
a force act against it. The magnetic field creates a twisting force or torque perpendicular 
to the field and the resulting circular motion is called precession. This movement occurs 
at a specific frequency (f0) which is proportional to the strength of the magnetic field 
(B0) and the gyromagnetic ratio (). This relation is expressed by the Larmor equation 
[7]–[9]: 
f0= B0  
 
As explained before, we won´t focused on a specific nuclei behavior (quantum model), 
instead we would take into account the sum of the magnetic properties that would 
create what we call net magnetization, denotated with letter M (Figure 1). This vector 
M follows the behavior dictated by the classical model. When magnetic perturbations 
are not present, this net magnetization it is aligned with the main magnetic field created 
by the scanner (B0). Nonetheless, whenever we apply a radiofrequency pulse, the global 
magnetization is altered flipping the net magnetization vector so is no longer align with 
B0 and precesses on its new direction. 
 
Figure 1. Nuclei under a magnetic field (B0). Nuclei Precession. [10] 
 
Resonance and Excitation 
 
Even though all particles with non-zero spin undergo precession under a magnetic field 
(Earth´s magnetic field is always acting) not all of them experience what we call 
resonance. This event is defined as an oscillating response to an external input energy 
over certain frequencies, close to the Larmor frequency. In other words, a transfer of 
energy takes place. 
 
The protons of a sample precess in both, parallel and antiparallel directions (Figure 2). 
Since there are more nuclei precessing in the parallel direction the net magnetization 
vector would follow the direction of the magnetic field whenever the system is at 
equilibrium. Subsequently, when we proceed with the acquisition of the study, the 
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patient is irradiated with an electromagnetic RF energy pulse with a frequency equal to 
the Larmor frequency (resonance). This event makes some of the nuclei that were 
precessing on the parallel direction (low-energy) flip to the antiparallel direction. 
Consecutively, the net magnetization vector decreases with time on the longitudinal axis 
(B0 direction) and starts growing on the transversal axis (Mxy) (Figure 2). After some time, 
the RF energy is released at the same frequency while the nuclei adopt their initial state. 
Both recoveries of equilibrium by the magnetization vector, the longitudinal and 
transversal, are independent events. The emission of energy due to the relaxation 
process is recorded by the antennas of the MRI scanner constituting the MR signal.  This 
physical process, which occurs when nuclei placed in a magnetic field absorbs and emits 
energy is what is denoted as nuclear magnetic resonance (NMR). 
 
 
Figure 2. RF Excitation  [11]. 
Longitudinal Relaxation  
  
Longitudinal Relaxation or T1 relaxation is the process where the net magnetization 
vector (M) recovers its initial value (M0) parallel to the main magnetic field (B0). This 
process is described with an exponential function where T1 is a first-order time constant 
of this function. It can be seen as the time need to recover 63% of the magnetization 
vector initial value (Figure 3). 
 
This relaxation occurs due to the energy transference from the nuclei to the external 
environment in the form of heat. This transfer of energy needs to be done with 
molecules of the surrounding that moves with a frequency close to the Larmor 
Frequency. This explains why different tissues have different T1 values, since not always 
the energy is transferred from the nuclei to the surroundings with the same efficiency. 
In the case of solids, the movement is limited, and liquids exceed the Larmor frequency 
because their molecules move to fast. A good example for short T1 is fat, since the speed 






                 Figure 3. T1 Relaxation [4].                                                                      Figure 4. T2 Relaxation  [4]. 
 
Transversal Relaxation  
 
Transversal relaxation or T2 relaxation is the process where the transverse component 
is lost with time. The transverse component of the magnetization vector (M) is denoted 
as Mxy. The T2 value is the time required by a specific tissue to lose 37% of the transversal 
magnetization vector (Figure 4) [13]. This type of relaxation takes place at a faster rate 
than Longitudinal Relaxation 
 
After the RF pulse is released, maximum transversal magnetization is accomplished, and 
a sinusoidal signal know as free induction decay (FID) is created and recorded by the 
antenna. Both, FID and Mxy decay with time due to magnetic inhomogeneities created 
by the sample (intrinsic) and the phase coherence is lost. T2 is the decay time caused by 
intrinsic magnetic inhomogeneities and T2* is the one created by intrinsic and extrinsic 
magnetic inhomogeneities since the main magnetic field is not perfectly homogeneous.  
 
Acquisition parameters: Repetition Time (TR) and echo time (TE)  
 
Repetition Time (TR) is the time between two RF excitation pulses where a T2 decay 
and a T1 recovery takes place. Depending on the type of sequence used, the TR value 
will range from a couple of milliseconds to more than 10.000 milliseconds.  A long 
repetition time will allow the spins of the tissue to align with the main magnetic field. 
On the contrary, a short RT won´t let the spins to fully relax to their initial state before 
another measurement takes place [4]. 
 
Echo Time (TE) is the time between the RF excitatory pulse (900) and the peak of an 
induced echo by a 1800 RF inversion pulse (or gradient field with a polarity reversal).  At 
time TE the readout takes place [4].  
 
To generate a T1-weighted image a short TR and a short TE are needed. While the nuclei 
are recovering the longitudinal relaxation a maximum difference in that recovery needs 
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to be achieve, and this is possible with a short TR. A short TE helps minimizing the T2 
decay [14]. 
 
In contrast, to generate a T2-weighted image, a long TR and a long TE are needed. Using 
a long TR helps minimizing the effect of the T1 recovery. The T2 difference is achieved 
by using a long TE so the dephasing can take place [14]. 
 
 
Figure 5.TE and TR parameters [15] . 
 
Typical Sequences: Spin echo and Gradient Echo  
 
Spin Echo (SE) is a sequence that make use of a secondary RF excitatory pulse that 
induce a 180 degrees inversion in the protons in order to achieve the generation of an 
echo of the signal. The first 900 RF pulse converts the net magnetization vector M0 to 
Mxy with a phase coherence that starts to decay (T2* relaxation). At time equals TE/2 a 
secondary RF excitatory pulse is applied (1800), and it leads to phase coherence at time 
TE. The usage of this inverting pulse causes the nuclei to only experience the intrinsic 
inhomogeneities and its dephasing effects, therefore it only depends on T2 and not 
T2*[4]. 
 
Unlike SE, Gradient Echo (GRE) sequence only makes use of a unique RF pulse followed 
by the application of gradient which accelerates the dephasing. Subsequently, a 
rephrasing gradient is applied (same strength but different polarity) and the FID signal 
or echo is generated. In this case the T2* effect is not cancelled out and the acquisitions 
are normally weighted in T2* or T1 [16]. 
 
1.2.2 Perfusion in MRI 
 
Perfusion is the flow of a fluid, blood in this case, through the circulatory system to an 
organ or tissue. Depending on the organ or tissue the perfusion measurements diverge, 
and it might differ its result for different pathologies. For this purpose, contrast agents 
such as gadolinium (for MRI) or iodine (for CT) are injected in the patient. These 
molecular compounds have specific magnetic characteristics, paramagnetism in the 
case of gadolinium, different from the surroundings that can be detected by the MRI 
scanner increasing the contrast in tissues where it accumulates.  
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1.2.2.1 Myocardial perfusion assessment 
 
Myocardial perfusion is usually assessed by the calculation of parameters that 
characterize the first pass of a bolus (contrast agent) in the myocardium. Through 
mathematical modeling it is possible to obtain myocardial perfusion parameters 
quantitatively; however, this quantitative analysis implies many barriers such as time-
intensive processing or different assumptions that are not fulfilled by every patient.  
 
For these reasons, many researchers have proposed semi-quantitative measurements 
of myocardial perfusion directly obtained from the Signal Intensity-time curves. These 
measurements may offer a rapid diagnosis since a visual assessment is possible without 
the need of difficult quantifications. Among different semiquantitative measurements, 
the upslope generated by the contrast first pass is easily calculated with the aid of a 
linear fitting performed on the curve. This method has shown great accuracy and 
reproducibility [17]. In order to correct for any difference caused by factors like different 
injection velocity, animal’s weight or bolus compactness, two upslopes are calculated, 
one from the myocardium and other one from the left ventricle. An example is depicted 
of Figure 6. Subsequently, the myocardial upslope is divided by the left ventricle 






Figure 6. Semi-quantitative method for myocardial perfusion assessment. 
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1.2.2.2 Perfusion imaging methods: DSC, DCE and ASL [21]    
  
There are three methods used in MRI for the study of perfusion: Dynamic Susceptibility 
Contrast (DSC), Dynamic Contrast Enhanced (DCE) and Arterial Spin Labeling (ASL). The 
first two methods make use of an exogenous intravenous contrast agent such as 
gadolinium, while the third one does not make use of any intravenous bolus.  
 
DSC is a technique where the first-pass of a contrast agent is recorded as a result of a T2 
or T2* weighted image acquisition, meaning that the signal intensity decays when the 
exogenous contrast agent arrives. This is achieved with the usage of sequences such as 
gradient or spin echo. Data acquired with this technique can be used to generate 
parametric maps (BF or BV) by converting the signal-intensity time curves into contrast-
concentration time curves in every pixel of the image.  
 
DCE technique acquires T1 weighted images and generates a signal-intensity time curve 
conveying information about permeability, perfusion, surface area and extracellular 
space. This technique is based on a two-compartment pharmacokinetic model where 
the intensities are converted into concentration. 
 
ASL technique is characterized by the use of an endogenous contrast consisting of 
labeled blood’s water molecules with RF pulses. When these labeled molecules arrived 
at the organ under study, the signal intensity is reduced. Normally, the procedure is 
carried out by acquiring two images, one previous to the magnetization labeling and 
other one after the molecules have been labeled. Then, both images are subtracted. 
Even though this technique is non-invasive, it offers low Signal-to-Noise ratio, contrast 










1.2.2.3 Blood Oxygenation Level Dependent (BOLD) contrast 
 
Blood Oxygenated Level Dependent (BOLD) contrast arises from oxy-hemoglobin and 
deoxy-hemoglobin regional concentration. The first paper describing magnetic 
properties of oxy- and deoxy- hemoglobin by Pauling et al. stated that oxyhemoglobin 
has no unpaired electrons and is diamagnetic [23]. On the other hand, deoxyhemoglobin 
has unpaired electrons and presents paramagnetism. The unpaired electrons of the iron 
center caused by the released of oxygen explains why this molecule becomes highly 
paramagnetic.  The idea of using oxygenation level as a measurable contrast in MRI was 
developed the first time by Owaga et al. in 1990 [24]. 
 
The deoxyhemoglobin concentration leads to the lowering of T2 and T2* relaxation 
times. The local field changes caused by the presence of deoxyhemoglobin triggers 
frequency changes and phase shifts of the spins responsible for T2 shortening [25][26]. 
 
1.2.3 MRI applications in the heart 
 
1.2.3.1 First-Pass Perfusion MRI of the myocardium 
 
Myocardial perfusion is a great marker of cardiac pathologies. Many heart diseases 
relate to the lack of myocardial perfusion due to poor functioning of the coronary 
arteries, responsible for myocardial irrigation. MRI is widely used in routine clinical 
applications for assessing heart perfusion using an image acquisition method known as 
first-pass perfusion.  
 
This technique makes use of an exogenous contrast agent with certain magnetic 
characteristics that can be detected by the MRI scanner. Particularly, gadolinium with 
its paramagnetic features is a good choice for this technique. Once the contrast agent 
has been injected intravenously, the first pass of the contrast bolus through the 
myocardial tissue will be recorded by a T1-weighted image acquisition. Regions of the 
myocardium with reduced perfusion will be characterized by lower intensities in the 
image [17]. 
 
Some important features regarding this technique are: high temporal resolution, short 
acquisition time and good in-plane resolution. Is important to acquire images every one 
or two beats to properly record the perfusion. Since the heart is responsible for pumping 
blood through the circulatory system it has a characteristic movement caused by the 
continuous relaxation (Diastole) and contraction (Systole) of its chambers (ventricles 
and atria) shown in Figure 7. In order to avoid the artifacts caused by this continuous 
movement, a short acquisition time is required. Moreover, a good in-plane resolution is 




The appropriate way to study myocardial perfusion is by acquiring images of the short 




Figure 7. Hearts Anatomy (A) and Heart’s Planes (B)  [27][28]. 
 
1.3 Antecedents and state of the Art 
 
So far, myocardial perfusion is approached invasively using Gadolinium as main contrast 
agent. This technique is the preferred option for cardiac  function and structural 
anatomy assessment since it offers accuracy and spatial resolution [29]. This type of 
paramagnetic contrast was first approved for clinical studies in 1988, when the first 
gadolinium-based contrast agent (gadopentetate dimeglumine) was available 
particularly for MRI scanner and marketed as Magnevist [30]. From that date, many 
clinical and research groups have taken advantage of contrast-enhance MRI using 
gadolinium for functional studies of organs such as heart or brain. Regarding myocardial 
perfusion, it was first practice in 1990 by Atkinson et al. using a GRE sequence and a 
gadolinium-based contrast agent (Gd-DTPA) in a rat animal model [31]. Since then, 
improvements have taken place on the scanner hardware, such as magnetic field 
strength or gradient coils, different contrast agents with diverse magnetic properties 
and pulse sequences [32].   
 
Up to now, the Medical Imaging Laboratory at Hospital General Universitario Gregorio 
Marañón does not have any protocol regarding the study of myocardial perfusion for 
small animals. To the best of our knowledge, there are no implemented protocols for 
myocardial perfusion using a 7 Tesla scanner BioSPec 70/20 USR (ultra-shielded) from 
Bruker Corporation. For this reason, one of the major goals of the study was the 
implementation of such protocol based on papers like those published by Nierop et al. 
and Coolen et al. [33], [34] as guidance for our project. Both investigations focused on 




Once this first protocol was implemented, we intended to test other innovative 
techniques based on the BOLD principle. Some previous methods have been proposed 
using BOLD signal in preclinical studies for the study of ischemic strokes[35]. Cristina 
Sainz, in her final thesis, used BOLD principle for perfusion assessment with DSC or DCE 
techniques in rat’s brain [36]. Taking her positive results as motivation, this project aims 
to translate this innovative endogenous contrast agent to a non-static organ such as the 
heart. Therefore, this project will study the feasibility of the new contrast based on FiO2 
changes.  
 
Many research projects are conducted regarding the study of myocardial perfusion 
using BOLD MR imaging. So far, their main goal was the study of medical conditions 
related to blood supply in the myocardium like scar tissue, infarct, edema, ischemia or 
coronary artery disease [37]–[41]. Most of the investigations regarding BOLD imaging 
focused on the detection of T2 and T2* changes in response of the administration of 
pharmaceutical stress agents or vasodilatory drugs such as DIP (dypiridamole) and 
adenosine in cardiac stress test [42][40]. Since BOLD implies very low signal to noise 
ratio, high magnetic field inhomogeneities or motion artifacts improvements regarding 
this technique are needed so as to translate this innovative technology to the clinical 
field. For this reason, new research show the utility of making use of apnea periods that 
generate measurable BOLD signal changes [43]. Preclinical studies are being performed 
using small animals, like rats, or big animal models in canine and porcine studies with 
increasingly positive results. Nowadays the main goal is to detect small changes in the 
oxygenation of the cardiac muscle (different regions), difficult to achieve with low SNR 
and contrast resolution. One of the latest contributions (May 2019) has been performed 
in canines using carbon dioxide as oxygen substitute (hypercapnia) to detect myocardial 
oxygenation through BOLD imaging [44].  
 
To our knowledge, there are no previous studies performed on small animals where a 
bolus of deoxygenated blood is produced with the short inhalation of Nitrogen for the 
assessment of the first pass perfusion in the myocardium. As previous studies regarding 
BOLD principle where SSFP sequence (steady state free precession) is used, this project 















Among all the organs where perfusion has proven to be a powerful tool for diagnosis, 
this project will focus on the myocardium (heart’s muscle). According to the World 
Health Organization, approximately 17.9 million people die every year due to 
cardiovascular diseases which is a 31% of all deaths [45]. For this reason, many efforts 
are now being put on its prevention and diagnosis, since an early assessment makes a 
huge impact on the outcome of this type of medical condition. 
 
This project was performed at Hospital General Universitario Gregorio Marañón at the 
Unit of Experimental Medicine and Surgery. In particular, the Medical Imaging 
Laboratory of such unit has one of the most innovative and complete resources for 
preclinical imaging diagnosis nationwide [46]. Apart from fluorescence tomography, 
PET, CT-PET, CT or optical imaging, this research lab holds a 7 Tesla MRI scanner. This 
device has been the key for studies related mainly to neuroimaging, so embarking a 
research project about the heart and its cardiovascular diseases would open up the 
range of possibilities offered by this entity to other research groups or laboratories. At 
the moment, this laboratory had only acquired multiplanar cine studies of the heart, but 
nothing related to its perfusion. For this purpose, the first motivation of the project was 
to implement the first-pass of a gadolinium contrast agent through the heart 
myocardium in rats. The protocol was based on previous studies performed by other 
research groups detailly explained in papers published by Nierop et al. and Coolen et al. 
[33], [34]. Both projects used a scanner from Bruker corporation but none of them made 
use of the same device model. Therefore, an implementation of the acquisition process 
with all its parameters was necessary for the Experimental Medicine and Surgery unit at 
hospital. 
 
The usual contrast agent used for myocardial perfusion in MRI studies contains 
gadolinium. This type of contrast is administrated intravenously, and it has a very high 
financial and economic cost. In addition to this, many adverse effects are nowadays 
being proven such as brain depositions of the contrast [47]. Likewise, vulnerable 
patients like pregnant women and patients suffering from kidney disorders are not 
recommended to go through this type of diagnosis technique. In order to overcome all 
these untoward effects and go a step further on this investigation, some studies were 
performed using an innovative endogenous contrast agent, the patient’s own blood. 
This new method relies on the BOLD principle where the paramagnetic characteristic of 
the deoxyhemoglobin is stated. Consequently, the bolus of endogenous contrast agent 
is created by changing the fraction of inspired oxygen (FiO2) by short periods of time 
that will be screen by the scanner due to the changes produced in the overall magnetic 
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field. This new approach can be harnessed to bring benefits such as non-invasiveness or 
the availability for the vulnerable groups of patients previously mentioned. This is 
further explained in section 7.1 where there is a detail explanation of the socio-
economic impact of this new approach.  
 
At the present time, this innovative contrast agent was tested by Cristina Sainz in her 
bachelor thesis where different FiO2 were exanimated for the study of brain perfusion 
[36]. Her job performed at the same facilities had obtained highly positive results in 
brain, which motivated us to translate this technique to other organ, the heart. It is 
highly convenient for a research institute like the Medical Image Laboratory at Hospital 
General Universitario Gregorio Marañón to have a research branch dedicated to such 
new contrast agent. This is intended to fill gaps in the existing set up and introduce new 
expertise on the field by implementing this protocol in this laboratory with small animal 
models using Nitrogen as oxygen substituent for the apnea process in order to produce 
BOLD signal. 
 
2.2 Alternative Designs 
 
This section is intended to offer an overview of different alternative techniques or 
measurements that could have been used in the project. Therefore, none of the 
concepts and ideas explained in the following paragraphs have been implemented on 
our study mainly due to its high computational cost or the side effects that could have 
been caused by other modalities. 
 
The most common parameters studied in perfusion are: Blood volume (BV), Blood Flow 
(BF), Mean Transit Time (MTT) and Time to Peak (TTP). These measurements are 
normally represented in parametric maps, where different colors are used as a code for 
the study of the organ’s activity [48]. 
 
- Blood Volume is defined as the amount of blood circulating or arriving to a tissue 
in milliliters divided by the mass of the tissue that is being perfused (mL/100g).  
- Blood flow is the movement of blood through a tissue, measured as blood 
volume per unit time divided by the mass of the tissue (mL/s/100g).  
- Mean Transit Time is the amount of time blood is stablished in the tissue under 
study measured in time units (seconds).  
- Time to Peak is the time between the injection of a contrast and the maximum 
signal measured in time units (seconds).  
 
Mean Transit Time (MTT), Blood Volume (BV) and Blood Flow are related by the 
following equation:  
𝐵𝑙𝑜𝑜𝑑 𝐹𝑙𝑜𝑤 (𝐵𝐹) =
𝐵𝑙𝑜𝑜𝑑 𝑉𝑜𝑙𝑢𝑚𝑒 (𝐵𝑉)
𝑀𝑒𝑎𝑛 𝑇𝑟𝑎𝑛𝑠𝑖𝑡 𝑇𝑖𝑚𝑒 (𝑀𝑇𝑇)




All these parameters can be calculated developing tough mathematical models. 
However, this quantitative analysis offers many drawbacks like time-intensive 
processing or several assumptions that are not fulfilled by every patient. In addition, 
these parameters are mainly obtained for static organs such as brain since motion 
presented by organs like the heart would make the calculations inaccurate and difficult 
(a perfect registration would be required). Because of this, this project has focused on 
the calculation of semi-quantitative measurements suggested by many researchers and 
obtained directly from the intensity curves. 
 
In terms of image modality, a common choice for perfusion studies in the heart is SPECT 
or PET (nuclear medicine). This technique makes use of a radioactive isotope, such as 
technetium, to study the heart’s muscle function and its perfusion.  
 
Even though this modality is used in many hospitals on a daily basis, we have decided to 
perform our study using magnetic resonance imaging (MRI). Apart from the organ’s 
function, MRI offers the option of studying structural anatomy with the same 
acquisition, being one of the most accurate and precise techniques used nowadays. 
Another drawback of nuclear medicine is related to the application of a radioactive 





The main objectives of this work are to implement the use of gadolinium as a contrast 
agent for first-pass perfusion of the myocardium and study the viability of a novel 
approach to evaluate perfusion using deoxyhemoglobin as an endogenous contrast 
agent by reducing oxygen saturation. The specific aims are: 
 
 Implement a first-pass perfusion protocol using Gadolinium as contrast in MRI. 
 
 Quantify the curve up-slope of different regions as a semiquantitative 
measurement for perfusion using Gadolinium as contrast. 
 
 Design a GUI implemented on MATLAB software for the interactive assessment 
of perfusion parameters. 
 
 Set up a convenient MRI sequence for the acquisition of images using FiO2 as an 
endogenous contrast agent. 
 
 Validate FiO2 contrast studies against the standard: Gadolinium perfusion. 
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3. Materials and methods 
 
3.1 Planning and Overall Design 
 
The principal objective of this project is to study the feasibility of the usage of 
deoxyhemoglobin as an endogenous contrast agent for myocardial perfusion by  
implementing first a first-pass perfusion protocol using gadolinium-based contrast 
agent. Before explaining each material used up to this end, two brief workflows are 
presented in Figure 8 and 9. The first figure represents the setting related to the 
Gadolinium implementation process. The second one refers to the usage of FiO2 change 
as contrast agent.  
 
 
Figure 8. Workflow of Gadolinium-based contrast agent acquisition. 
 
The process using Gadolinium is described in Figure 8, where an animal, rat in this case, 
is placed inside the MRI gantry covered with a surface coil wrapping its chest to record 
the MRI signal (will be used to reconstruct the image) with the aid of a volume coil that 
creates the excitatory pulses. The images are acquired by the MRI scanner over this 
process so myocardial perfusion can be studied. The animal is constantly being 
monitored by an ECG and respiratory sensors that are connected to a Control module 
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by optic fiber, so the respiratory rate and the electrocardiogram are recorded. The ECG 
signal is furtherly used for the MRI triggering mode explained in the following sections. 
Moreover, this module is connected to a computer which stores and processes all this 
information.  
 
To study the myocardial perfusion, a gadolinium bolus is intravenously injected in the 
rat’s tail ten seconds after the beginning of the acquisition. More details of the contrast 
agents used and the animal model are described in sections 3.2.3 and 3.2.6. 
 
 
Figure 9. Workflow of deoxyhemoglobin endogenous contrast agent acquisition. 
 
The scheme in Figure 9 describes the general design of the second experiment, where 
the FiO2 was used as contrast agent for the study of myocardial perfusion. There are two 
additional devices with respect to Gd experiment: the pulse oximeter and a gas mixer. 
The pulse oximeter is connected to a second control module by optic fiber and it is used 
to monitor the animal and to record the FiO2 changes produced by the gas mixer. The 
gas mixer uses the GSM-CommVS software [50] for the O2/N2 adjustment. At the 
beginning of the acquisition the animal inhale 100% Oxygen. Afterwards, the software 
changes to 100% Nitrogen automatically for 25/60 seconds. Finally, the animal is 





3.2.1 MRI Scanner 
 
The MRI scanner employed for this project was a 7 Tesla BioSPec 70/20 USR (ultra-
shielded) from Bruker Corporation (Figure 10). 
 












Figure 10. MRI scanner. 
3.2.2 MRI Coils 
 
For this project, two types of coils were used: surface and volume coils. Like the scanner, 
these two radiofrequency coils are from Bruker Corporation. The volume coil can either 
serve as receiver or emitter, and in this case was used as a transmitter coil placed inside 
the scanner surrounding the animal. This type of coils in emitter mode offer good 
homogeneous signal in the entire sample.  
 
On the other side, the surface coil was used as a receiver coil since it covers the animal’s 
chest perfectly, offering higher signal to noise ratio than a volume coil. Furthermore, it 
has a four-coil phased array configuration which enables a parallel acquisition of the 
image that will improve time resolution. 
 
3.2.3 Animal Model  
 
The animal model used for the study is a Wistar Rat, an albino breed commonly used for 
scientific research. A total of four healthy adult rats were used: two males and two 
females. The Regulatory Framework related to animal experimentation is explained in 






Figure 11. Wistar Rat used for the experiments [51], [52] . 
 
3.2.4 Animal monitoring: Pulse-Oximeter, Cardiac monitoring, Respiratory 
monitoring, Temperature monitoring 
 
During MRI acquisition the animal was precisely monitored. The following components 
from SA Instruments, Inc. (manufacturers of imaging compatible devices for small 




A Pulse Oximeter is a noninvasive device used to measure the animal’s pulse and its 
oxygen saturation (SpO2). The SpO2 refers to the proportion of oxyhemoglobin and 
deoxyhemoglobin carried out by red blood cells. This is done with the aid of two 
different light wavelengths, red and infrared, and a light detector mounted on a clamp. 
The light absorbance at two different wavelengths (red and infrared) is measured, and 
the arterial SpO2 is obtained by using Beer’s Law as a function of the ratio of the two 
absorbances  [53]. 
 




The cardiac monitoring device makes use of three electrodes placed intracutaneously in 
the animal’s limb as shown in Figure 13. These electrodes record the electrocardiogram 
(ECG). 
 
In addition, the output of this device is used for cardiac triggering. This means that the 
MRI scanner will only acquire data at certain time window after the R-wave of the ECG, 




      
 




The respiratory sensor is based on a pressure pad placed at the animal’s back (Figure 12 
and 13 blue cable). It is a noninvasive method of obtaining the breathing rate and 
controlling if the animal is being properly anesthetized.  
 
Temperature monitoring  
 
The animal’s temperature was also recorded by a sensor placed at the pressure pad used 
for breathing monitoring. To keep temperature, a Circulating Warm Water Pump is used 










The anesthesia system is composed by an anesthesia vaporizer from SurgiVet brand 
connected to a methacrylate box where the animal is placed and anesthetized at the 
beginning of the experiment. Once the animal is fully anesthetized, it is moved to the 
scanner bed where it remains anesthetized with a tube coming from the vaporizer and 
connected to a mouthpiece directly placed on the animal’s mouth.  
 
The parameters for the animal anesthesia system on Figure 15 are explained on 
section 3.3.1.2. 
 
             
 
Figure 15. Animal anesthesia system. 
 
3.2.5  Gas Mixer 
 
The percentage of Oxygen inhaled by the animal is set with the gas mixer shown in 
Figure 16. This is the GSM3-Gas Mixer (CWE, Inc.). The device has two control modes: 
Local and Remote. For this project, the Remote mode was more convenient so changes 
between different mixtures were done automatically by setting some parameters in its 
own software. A RS-232 cable was used to connect the gas mixer to the computer for 
the remote mode. For our purposes we used two mixtures of two gases: 100% Oxygen 







Figure 16. GSM3-Gas Mixer. 
 
3.2.6 Gadolinium and Injection Pump 
 
Gadoteridol (0.5 mmol/mL) (ProHance, Bracco, Italy) is contrast agent used. This 
contrast agent is intravenously injected to the animal with the aid of an injection pump 
(Harvard apparatus, USA) that allows the user to set parameters such as volume and 
flow (Figure 17).  
 
 
    
Figure 17. Injection Pump by Harvard Apparatus. Gadoteridol (ProHance) [54]. 
 
3.2.7 Software: MATLAB, gas mixer, monitoring, MRI scanner 
 
Four different software platforms were used for the project: MATLAB, PC-SAM, 




MATLAB was the chosen platform for creating Graphic User Interfaces (GUI) that will be 
in charge of the image postprocessing and the perfusion parameters assessment. The 






ParaVision software is a preclinical software from Bruker manufacturer for setting all 
the acquisition parameters such as Echo Time, Repetition Time, Image Size and Field of 




The devices in charge of the animal monitoring (cardiac, respiratory and pulse oximeter 
monitoring, SA Instruments Inc., USA) are controlled by the software, PC-SAM, shown in 








Figure 19 shows the software used by the Gas Mixer settings in remote mode control. 
On the top of the screen, MIX 1 and MIX 2 represent our two mixtures model for 
Nitrogen and Oxygen. On the left down corner, there is a sequencer where the time 
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settings of each mixture can be stablished. The version used for the project is GSM-




Figure 19. GSM-CommVS software. 
3.3 Methods 
 
The project is divided into two subprojects: the implementation of the use of 
Gadolinium for a first-pass perfusion and the feasibility of the usage of different FiO2 as 
contrast agent by comparing both results. The first part is used as general basis for the 
endogenous contrast agent (second part).  
 
3.3.1 Implementation of a first-pass perfusion protocol using Gadolinium as 
contrast agent 
 
3.3.1.1 Image Sequence 
 
In this project two sequences were studied: True FISP and EPI. The EPI sequence was 
tested at first.  Echo Planar Images (EPI) is a fast gradient echo sequence where data for 
an entire 2D plane is obtained only with one RF-excitation, meaning that one entire 
image will be made up with one repetition time.  
 
For the use of the EPI sequence, a T2/T2*-weighting was implemented. Nevertheless, 




After some literature research the True FISP sequence was considered. The parameters 
selected for this sequence were based on two papers: “Mouse Myocardial First-Pass 
Perfusion MR Imaging by Coolen et al. and “Quantitative First-Pass Perfusion MRI of the 
Mouse Myocardium” by Nierop et al. [17], [33].  
 
The True FISP sequence is a Gradient Echo sequence (GRE) that refocuses both, FID and 
Echo signals. This sequence is weighted on T1, therefore our contrast is expected to 
increase the intensity of the image (shortens time t1). In order to implement the process 
several parameters were changed and tested using five different acquisitions. These 
parameters were: trigger, quantity of gadolinium and slice thickness. All the parameters 
including TR, TE and number of frames are shown on Table 2. All the acquisitions took 
approximately 100 seconds (it depends on the heart rate of the animal) with a FOV of 
30x30 mm. 
 
Since one of the main goals of the project is implementing a new sequence for the study 
of myocardial perfusion in a 7 Tesla BioSPec 70/20 USR MRI scanner, different 
parameters such as the gadolinium, triggering and slice thickness of the image are 
tested. This is explained in section 3.3.1.3. 
 
Echo Time 0.6/1            (ms) * 
Repetition Time 1.2/2   (ms)                              * 
Number of Slices 1 
Slice Thickness 1.5/2            (mm)                            *  
Field of View 30x30           (mmxmm) 
Image Size 32x64            
Number of frames 600      
Duration of the sequence 100              (s) 
Parallel Acceleration factor 1.60 
 
Table 2. Proposed sequence parameters for True FISP. (*) These parameters have two values since they were tested 
for the implementation. 
 
3.3.1.2 Study protocol 
 
The studies and acquisitions carried out in this part of the project were done with two 
male Wistar rats (300-400 grams). At the beginning of the process the animal was placed 
in the induction chamber so it could be easily anesthetized. The gas used for this purpose 
was a mixture of pure oxygen with Sevoflurane (7%), highly used in inhalational 
anesthesia, with a flux of 600 cc/min. After the induction was completed the animal was 
moved to the scan bed and the flux was reduced to 300 cc/min with Sevoflurane (2-3%). 
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The anesthesia was kept up to the end of the experiment so the respiratory rate could 
be maintained between 40-50 rpm. 
 
After the animal was well positioned (prone position) at the scan bed, three needle 
electrodes were placed on three of its limbs (two front legs and one rear leg), the 
respiratory sensor was placed on its back and the temperature sensor was placed on its 
rectum.  At this point all constants (temperature, cardiac rate and respiratory rate) could 
be recorded. All these steps were carefully followed for every acquisition. 
 
A total of five acquisitions took place. The first one was done based on the parameters 
specified on those two papers previously mentioned by Coolen et al. and Nierop et al. 
with cardiac triggering, a slice thickness of 1.5 mm and 0.3 mL of Gadolinium. The second 
acquisition was performed using the same rat, adding a second trigger: respiratory 
triggering. Finally, the remaining acquisitions were performed using the last animal. 
Here the amount of Gadolinium was changed from 0.3 to 0.23 mL and the slice thickness 
was increased to 2 mm.  
 
After every acquisition, the images obtained with the MRI were processed and studied 
as explained in section 3.3.1.5. 
 
3.3.1.3 Signal Intensity-time curves characterization (acquisition parameters) 
 
All 600 time frames of each study are represented for both data in graphs where the x-
axis represents the time in seconds and the y-axis shows the signal-intensity values. The 
first-pass peak of the signal enhancement was obtained for every acquisition. The up-
slope of the Signal Intensity-time curves was used as semiquantitative measurements of 
perfusion dividing the myocardial up-slope by the left ventricle lumen up-slope.  
 
The implementation process of the Gadolinium protocol includes many parameters that 
can be modified and subsequently tested. Among the great variety of parameters, three 
of them are compared in this project: trigger, gadolinium and slice thickness. These 
three parameters are studied with ROIs that enclosed the entire area of the myocardium 
and left ventricle respectively. Moreover, signals of four regions of the myocardium are 
presented so as to assess the perfusion depending on the myocardial region. 
 
Parameter 1: Cardiac and Respiratory Triggering 
 
First acquisition was performed using cardiac triggering. The MRI scanner acquired 
images after the detection of the R-wave of each cardiac cycle recorded in the ECG. The 
second one makes use of both, cardiac and respiratory triggering. Apart from acquiring 
right after each R-wave, the MRI scanner does not obtain images during the respiration.  
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Parameter 2: Gadolinium 
 
Secondly, the amount of Gadolinium was tested. The concentration of Gadolinium was 
kept constant among all the acquisitions, with a value of 0.5 mmol/mL. Two different 
amounts of Gd were compared: 0.3 mL (0.15 mmol) and 0.23mL (0.115 mmol). The 
experiment was performed with the third rat (acquisitions 3 and 5, further information 
in Table 3). 
 
Parameter 3: Slice Thickness 
 
Slice thicknesses of 1.5 mm and 2 mm were tested. Both acquisitions were performed 
with the same animal (see Table 3 acquisition 3 and 4 for further information) with a 
period of 15 minutes between each acquisition.  
 
 
Regional perfusion quantification 
 
For this analysis the Myocardium was divided into four segments previously explained 
in Figure 20, Section 3.2.1.3. Once again, myocardial and left ventricle Signal Intensity-
time curves were depicted for each region: septum, lateral, inferior and anterior 
myocardium wall.  
 
Table 3. Different acquisitions for the implementation of the Gadolinium study. 
 
3.3.1.4 Image Display and Anatomy Interpretation 
 
First image on Figure 20 shows both, the left and the right ventricles. The left ventricle 
myocardium, which is the one we are interested in, is the darker ring that surrounds the 
left ventricle, depicted on the third image in the same figure.  
 
Additionally, for our study purposes, the heart myocardium was divided into four 
regions (second image on Figure 20): Anterior Wall (A), Septum (S), Lateral Wall (L), and 
RAT\SPEC. TRIGGER GADOLINIUM  
(0.5mmol/mL) 
SEQUENCE SLICE  
THICKNESS 
TR TE NUMBER OF 
FRAMES 
Rat 1 (Acq. 1) 
305 gr  
ECG triggering 0.3 mL  
(0.15 mmol) 
True FISP 1.5 mm 1.2 ms 0.6 ms 600 







True FISP 1.5 mm 2 ms 1 ms 600 
Rat 2 (Acq. 3) 
411 gr 
ECG triggering 0.23 mL 
(0.115 mmol) 
True FISP 1.5 mm 1.2 ms 0.6 ms 600 
Rat 2 (Acq. 4) 
411gr 
ECG triggering 0.23 mL 
(0.115 mmol) 
True FISP 2 mm 1.2 ms 0.6 ms 600 
Rat 2 (Acq. 5) 
411 gr 
ECG triggering 0.3 mL 
(0.15 mmol) 
True FISP 1.5 mm 1.2 ms 0.6 ms 600 
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Inferior Wall (I). A comparative study will be done related to the different data obtained 




Figure 20. Midventricular short-axis image. 
3.3.1.5 Computing perfusion parameters 
 
A MATLAB code was developed so as to carry out image post-processing. Signal-intensity 
time curves were calculated, and the up-slope of each curve was used as 
semiquantitative measure for perfusion.  
 
Figure 21. Calculation of Perfusion Parameters. 
The workflow followed for the post processing is depicted in Figure 21. The images 
exported from the MRI scanner have DICOM format (Digital Imaging and 
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Communication On Medicine). The number of repetitions for this study was 600 to 
ensure that the signal generated by the contrast was well recorded. The size of each 
image is 32 by 64 pixels with a field of view (FOV) of 30x30 mm.  
 
After images are load in the software, one of the images is chosen as a template. Before 
displaying it, the template image is rescaled by multiplying the y-axis by 2 transforming 
it to a 64 by 64 image. The reason why it was acquired as a flattered image is because it 
improves temporal resolution and rescaling is a simple step that can be performed in 
the post-processing steps. Intensity values are adjusted improving the contrast 
resolution and making the ROI selection easier for the user. After the both ROIs are 
selected, one for the myocardium and the other one for the Left Ventricle lumen, two 
masks filled with 1 and 0 were formed representing both ROIs. All of these steps are 
represented in Figure 22. 
 
Once we have both ROIs, the masks are rescaled to the original size and multiplied by 
the 600 images. The results are two sets of 600 images, one having intensity information 
of the myocardium and the other set about the left ventricle. See appendix A for further 
information using a visual example.  
 
The average of the non-zero values is performed and a single intensity value is obtained 
per image.  
 
 





Once the intensities are represented, periodic outliers of high intensities are quite 
noticeable in the graph (specially for the myocardium).  This artifact is caused by the 
respiration and was eliminated by using a filter that removes intensities that exceed by 
a certain percentage he median intensity value. Both values, the number of intensities 
forming each group and the strength of the filter, can be set by the user. Groups of less 
than 20 are recommended since the up-slope of the signal changes rapidly and the filter 
could consider those values as outliers getting rid of important information for perfusion 
measurements.  
 
In Figure 23 both signals (left ventricle and myocardium) are displayed, and the outliers 









Once the signal is filtered, the base-line intensity value (before the injection) is 
subtracted from the signal by calculating the average value of the first 50 images. This 
rectifies any kind of inhomogeneity that could have been created by the surface coil.   
 
For the slope calculation two points from each signal were selected, one from the 
baseline (point B(x2, y2))and the other one close to the first-pass peak (point A(x1, y1)). 
Knowing the equation of a straight line, the slope “m” was calculated as follows:  
 







A good estimation of our curves related to the up-slope created by the contrast agent 
would be the following equation. S(t) represents the value of our signal at any time, t0 
is the starting point of signal rising. The slope is represented by letter “m”. 
 
{
𝑆(𝑡) = 0                      𝑡 < 𝑡0
𝑆(𝑡) = 𝑚(𝑡 − 𝑡0)      𝑡 > 𝑡0
      [17] 
 
The up-slope of the myocardium is normalized with the up-slope of the left ventricle 
lumen. This result is used as a semiquantitative measurement for perfusion.  
  
      
 
Figure 24. Example of two points selected for the slope calculation. Both figures represent Signal Intensity-time 
curves. Myocardium (right) and Left Ventricle (left). 
 
3.3.1.6 Graphical User Interface (GUI) 
 
A MATLAB Graphical User Interface (GUI) was created. All the steps can be seen in 
Appendix B.  
 
The steps followed by the GUI are the following:  
 
1. First, a pop-up window would let you navigate through the computer’s 
documents.  
2. A second pop-up window will show four different images that could be chosen 










Figure 25. Four different images that can be chosen as a template. On the right the pop-up window where you select 
the image. 
3. Now is the time for selecting ROIs. The INSTRUCTION window would tell you to 








4. Filter: a popup window will appear where the filter parameters should be 
specified.  
5. Once these parameters are chosen, both signals will be displayed. The green 
intensities are the outliers that will be deleted.  
6. For the up-slope calculation both signals will be displayed, and points A and B 
have to be selected manually. The slopes will be displayed on the right down 
corner of the interface. 
7. Seven options for representing the Signal Intensity-time curves are available: 
original signal, Original signal showing the outliers that have been deleted in 
green, filtered image (no outliers), signals with the slopes, myocardium signal, 
left ventricle signal and both signals with a smooth filter. All this information can 




Figure 27. Interface output. The Left Ventricle and the Myocardium Signal Intensity-time curves are displayed. The 
START (green) and EXIT (red) button are located on the upper right corner. The SAVE INFORMSTION (blue) button is 











3.3.2 Implementation of a first-pass perfusion protocol using changes of FiO2 as 
endogenous contras agent 
 
As we have implemented the process using gadolinium-based contrast agent, the first 
approach for the second implementation was to use the same sequence with its 
corresponding parameters.  
 
3.3.2.1 Hardware synchronization 
 
Unlike True Fisp sequence, EPI sequence offers the opportunity of synchronizing the MRI 
scanner and the gas mixer, meaning that the FiO2 start changing at the moment the MRI 
scanner begins the acquisition. For this purpose, the option “trigger out” is available in 
the EPI sequence, where a TTL signal of 5 volts will be continuously sent to a computer. 
Once the acquisition begins, this signal turned into 0 volts.  
 
However, the True Fisp sequence does not include this option, and the synchronization 
was performed manually using GSM-CommVS software, proposed by the manufacturer 
of the gas mixer, increasing the error caused by human delay.  
 
3.3.2.2 Pulse-oximeter characterization 
 
The signal produced by the pulse-oximeter must be perfectly characterized in order to 
implement the new protocol. This curve is produced by changes of FiO2 that create a 
bolus of deoxygenated blood. Parameters such as the time of 100% nitrogen, the tube’s 
length and the flow rate were tested by Cristina Sainz in her Bachelor Thesis [36]. She 
came to the conclusion that the tube’s length must be kept long (usual tube), a flow rate 
of 1l/min and 25 seconds of 100% N2. These variables were kept as stated for the first 
acquisition where True Fisp was used. 
 
Since the results obtained with the previous values were not optimal for this organ, the 
duration of the nitrogen was also modified. Different times were tested from 25 seconds 
to one minute. 
 




The first study performed for the use of FiO2 as endogenous contrast agent for 
myocardial perfusion were carried out with a True Fisp sequence. This sequence is 
explained in section 3.3.1.1 and the parameters are described in section 5.1 Table 4. In 
addition, previous BOLD imaging studies show a great interest on SSFP sequence since 




EPI sequence used for the brain in previous studies was tested with N2-based contrast 
agent in the heart with poor results. Therefore, this sequence was discarded due to its 
low temporal resolution. 
 
3.3.2.4 Study protocol 
 
The studies and acquisitions carried out in this part of the project were done with two 
female Wistar rats. All of them were adults (over six months) with a weight close to 250-
350 grams. The first part of the process remains unchanged from the experiment using 
Gadolinium. The animal was placed in the induction chamber so it could be easily 
anesthetized. The gas used was a mixture of pure oxygen with Sevoflurane (7%), highly 
used in inhalational anesthesia, with a flux of 600 cc/min. After the induction was 
completed the animal was placed to the scan bed and the flux was reduced to 300 
cc/min with Sevoflurane (2-3%). The anesthesia was kept up to the end of the 
experiment so the respiratory rate could be maintained between 40-50 rpm. Animal 
position and monitoring was similar to the previous experiment with Gd-contrast. 
 
A total of three acquisitions took place (one with EPI sequence and two with Fisp 
sequence). The last two were done based on the parameters specified by the 
implementation of Gadolinium. The acquisition perform with EPI sequence was rejected 
at the very beginning since it was not possible to obtain any signal from it due to its low 
temporal and spatial resolution. 
 
After every acquisition, the images obtained with the MRI were processed and studied 






4.1 First-pass perfusion protocol using gadolinium as contrast agent 
 
4.1.1 Structural Images  
 
An example of a time-series of first-pass perfusion is shown in Figure 28. This series of 
images obtained from our first acquisition (see Table 3 in Section 3.3.1.5 for more 
information) represents the right ventricle arrival, left ventricle, myocardium influx and 
washout. Five out of the 600-time frames were selected. The gadolinium was injected 
ten seconds after the MRI scanner started acquiring the study. The first image (time = 
0.5 seconds) represents an image before Gadolinium was injected. The contrast reaches 
the right ventricle at time 12.6 s and to the left one at 13.8 seconds. Myocardial influx 
occurs at time 16 seconds and the washout process takes place after 40 seconds till the 





Figure 28. Time series of cardiac images during the first-passage of a Gadolinium bolus. 
 
 
4.1.2 Analysis of the MRI signal change using Gadolinium 
 
The mean signal intensity values for the heart myocardium (blue signal) and the left 
ventricle (red signal) were calculated for every study. All 600 time frames are 
represented for both data in the following graphs where the x-axis represents the time 




As stated before, three parameters are compared in this project: trigger, gadolinium and 
slice thickness. These three parameters are studied with ROIs that enclosed the entire 
area of the myocardium and left ventricle respectively. All the following graphs 
represent the results are obtained with a True Fisp MR sequence after all the post-
processing.  
 
Parameter 1: Cardiac and Respiratory Triggering 
 
First acquisition (Figure 29) was performed using cardiac triggering. The second one 




Figure 29. Signal Intensity-time curve using Cardiac Triggering. 
 
 
Figure 30. Signal Intensity-time curve using Cardiac and Respiratory Triggering. 
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Parameter 2: Gadolinium 
 
Two different amounts of gadolinium were compared: 0.3 mL (0.15 mmol) and 0.23mL 
(0.115 mmol). The results can be observed in Figure 31 (0.23 mL) and Figure 32 (0.23 














Parameter 3: Slice Thickness 
 
Both curves, ventricle and myocardium, are once again represented as Signal Intensity-















Regional perfusion quantification 
 
In the following figures (Figure 35 and 36) myocardial and left ventricle Signal Intensity-
time curves were depicted for each region: septum and lateral, inferior and anterior 




Figure 35. Signal Intensity-time curve of the Lateral Wall (Image on the left) and Anterior Wall (Image on the right). 
 
 









4.1.3 Validation of the technique with the slope ratios 
 
The program explained in previous sections was used to obtain graphs from the four 
different parts of the myocardium: left wall, anterior wall, inferior wall and septum. 
Since the measurement of both slopes (myocardium section and left ventricle lumen) 
are highly dependent on the ROI chosen, a total of twelve measurements per region 
were obtained by different technicians. Then, a normalization step took place, where 
every myocardial slope was divided by the left lumen slope. The results for all these 48 
ratios (twelve per region) are depicted on Figure 37 with a box plot.  
 
 




4.2 First-pass perfusion protocol using changes of FiO2 as endogenous contrast 
agent 
 
4.2.1 Pulse-Oximeter Curve 
 
Before acquiring images using FiO2 as contrast agent, the curve created by the pulse-
oximeter must be characterized. This curve is created when the bolus of deoxygenated 
blood passes through the circulatory system (in this project this is measured in the rear 
limb of the animal). Figure 38 represents the signal obtained when the gas mixture of 
100% N2 is maintained for 25 seconds. Y-axis is the oxygen saturation (SpO2) and the x-






Figure 38. Pulse-Oximeter curve for 25 seconds of N2 
 
Since the amount of signal recorded by the MRI scanner with 25 seconds of 
deoxygenated blood was quite low, another acquisition was performed increasing to 60 











4.2.2 Analysis of the MRI signal change using FiO2  
 
As the previous experiment, the mean signal intensity values for the heart myocardium 
(blue signal) and the left ventricle (red signal) were calculated for every study.  
 
The same sequence with different amounts of inspired nitrogen are compared in this 
part of the project: 25 and 60 seconds of N2. The main goal is to proof if the MRI scanner 
is able to record alterations in the magnetic field produced by changes of FiO2. 
 
True Fisp sequence: 25 seconds N2 
 
All 1200 time frames are depicted for both data in the graphs of APENDIX C where the 
x-axis represents the time in seconds and the y-axis shows the signal-intensity values.  
 
True Fisp sequence: 60 seconds N2 
 
In the previous acquisition, a total of 1200 time frames were acquired so as to ensure 
that the signal was correctly recorded by the scanner. Since the endogenous contrast 
agent is inhale (not injected) it is thought to arrive more slowly to the tissue of interest.  
Even though, we have realized that 600 time frames were enough, so the later 




Figure 40. Signal Inensity-time curve with N2-based contrast agent. (60 seconds) 
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The following graph (Figure 41) represents both, the data recorded by the pulse-




























5.1 First-pass perfusion protocol using Gadolinium as contrast agent 
 
According to the objectives of this project, one of its goals is the implementation of a 
First-pass perfusion protocol using Gadolinium as exogenous contrast agent in a rat 
model.  The method uses an ultrafast imaging sequence for MRI known as True Fisp, so 
the first pass of a bolus is captured correctly. The fast passage of Gadolinium contrast 
and the high heart rate of the animal are not compatible with the acquisition of high 
contrast resolution images (Figure 28). Therefore, for the assessment of myocardial 
perfusion time resolution is prioritized over contrast resolution.  
 
After two ROIs were selected for each acquisition, the time course of the signal 
enhancement was depicted. All the results discussed for this section are in the form of 
Signal Intensity-Time curves of the Left Ventricle lumen and the Myocardium before, 
during and after the arrival of the contrast.  
 
5.1.1 Analysis of the MRI signal change using Gadolinium 
 
The Signal Intensity-time curves were studied to establish how different parameters 
may affect its shape and the data that will determine the semiquantitative 
measurement for perfusion and will successively validate the technique. Among all the 
variables that could have been analyzed, three of them were selected: the slice 
thickness, gadolinium and cardiac and respiratory triggering.  
 
Parameter 1: Cardiac and Respiratory Triggering 
  
The first variable to be examined is the triggering option offered by the MRI scanner. 
Many papers such as that one by Coolen et al. [17] make use of cardiac triggering, 
meaning that the machine will only acquire at a certain moment of the cardiac cycle 
monitored by the ECG. Apart from this option, the software offers the opportunity of 
using respiratory triggering on top of the cardiac one. In order to improve contrast 
resolution and to avoid movement artifacts cause by the respiration, one of our 
acquisitions was performed using both types of triggering. The result for cardiac 
triggering and cardiac plus respiratory triggering are depicted in Figure 29 and 30 
respectively. Both acquisitions were performed using the same animal in different dates 
(no intensities in the second acquisition show recirculation of the contrast agent due to 
the first acquisition).  
 
Both graphs show the same pattern: left ventricle signal reaches higher values than 
myocardium signal after contrast agent arrival. After the peak that represents the first 
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pass of the bolus, continuous recirculation of the contrast agent is recroded in both 
regions of interest (ventricle and myocardium). Apart from this, what is more striking is 
the fact that many points are lost on the up-slope of Figure 30. The missing data points 
may render it impossible to calculate the semiquantitative measurements of perfusion. 
Moreover, unlike the cardiac rate, the respiration is not completely periodic and varies 
greatly over time. Therefore, the time scale will be lost since is not possible to predict 
those data points deleted by the respiration triggering. 
 
For these reasons, the use of respiratory triggering was discarded. As predicted by 
Nierop et al. and Coolen et al. [17], [33]the correct way of acquiring this type of studies 
is using the ECG-triggering option.  
 
Parameter 2: Gadolinium volume 
 
The main purpose of this experiment was to test lowest amount of Gadolinium so as to 
avoid injecting greater amount of exogenous contrast agent than the necessary. The 
gadolinium-based contrast agent used for the implementation was Gadoteridol (0.5 
mmol/mL) marketed as ProHance. The molar concentration was kept constant over the 
entire experiment and changes were performed on the volume administrated to the 
animal. The fact that the administration was done intravenously increased greatly the 
speed of the contrast arrival to the area of interest.  
 
The same rat (rat number 3) was used for the study of this parameter and the following 
one. A total of three acquisitions were performed with 15 minutes in between. The 
reason for this lies in the fact that the contrast agent will recirculate after the first arrival 
provoking changes in the intensity of the acquired images. Figures 31-34 show a great 
amount of noise caused by this since the time was not probably enough to complete the 
washout of the contrast. Without taking this into account, the signals depicted in the 
images are sufficiently good to draw firm conclusions regarding these parameters.  
 
Two different volumes of Gadolinium were compared: 0.3 mL (0.15 mmol) and 0.23 mL 
(0.115 mmol). The results are shown in Figure 31 (0.3 mL) and Figure 32 (0.23 mL).  
 
A slight variation can be observed between both graphs: Figure 31 shows a more 
remarkable peak after the first bolus arrives to the left ventricle, meaning that a higher 
accuracy is achieved. This peak is important, since the semiquantitative measurements 
is based directly on the graph’s data. For this reason, a reduction of the contrast agent 







Parameter 3: Slice Thickness 
 
By increasing thickness more tissue is included in the same voxel thus increasing signal. 
Two different slice thicknesses were tested. At the beginning a slice thickness of 1.5 mm 
was set (following Nierop et al. [33] parameters),  followed by a second acquisitions 
increasing the slice thickness to 2 mm. The results are shown in Figure 33 and 34.  
 
No significant change was observed between both plots. Since the enlarge of the slice 
doesn´t show any improvement, the thickness was kept at 1.5 mm.  
 
Echo Time 0.6                (ms)  
Repetition Time 1.2                (ms)                                  
Number of Slices 1 
Slice Thickness 1.5                (mm)                              
Field of View 30x30           (mmxmm) 
Image Size 32x64            
Number of frames 600      
Duration of the sequence 100              (s) 
Gadolinium (0.5 mmol/mL) 0.3               (mL) 
Trigger ECG Triggering 
 
Table 4.  Final parameters used for the First-pass perfusion protocol using Gadolinium as contras agent. 
 
5.1.2 Validation of the technique with the slope ratios 
 
Since the technique puts strain on the ability of the technician in terms of ROI selection, 
a total of twelve measurements per region of myocardium were performed by different 
technicians of the department. The comparison among all these regions is carried out 
so as to validate two things: perfusion is taking place through all the myocardium and 
the parameter given by the slopes is consistent.  
 
First, we assume that all the animals in this project do not suffer any pathological 
condition. For this reason, we expect to obtain similar values from all four regions. In 
Figure 37, a graphic method was implemented to show the information through their 
quartiles.  
 
From the graphical representation we know the following results: 
- The average value for each region is: 0.5357, 0.4827, 0.5800, 0.5541. 
- The median value for each region is: 0.5319, 0.4646, 0.5901, 0.5700. 
 
The first value corresponds the left wall, then the anterior wall, inferior wall and finally 
the septum. Accordingly, our technique is quite consistent since both average and 
median are close to the same value (0.54 ± 0.04) in all cases. Furthermore, this result 
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also indicates that the perfusion is being correctly recorded by the scanner and this 
protocol can be used for further research.  
 
5.2 First-pass perfusion protocol using changes of FiO2 as endogenous contrast 
agent 
 
Apart from implementing the protocol of myocardial perfusion with gadolinium-based 
contrast agent, one of its main goals is the implementation of a First-pass perfusion 
protocol using changes in FiO2 as endogenous contrast agent in a rat model.  This 
method uses the same ultrafast imaging sequence used for the experiment of 
gadolinium. Furthermore, other MRI sequences such as EPI were taken into 
consideration so as to improve the technique and obtain greater results. 
 




Signal Intensity-time curves were obtained for both regions, the myocardium and the 
left ventricle lumen.  
 
The first study was performed with the EPI sequence originally proposed by Cristina 
Sainz [36]. As results were not optimal, we decided to use our previous setting with the 
gadolinium sequence as a template. First, apnea was induced for 25 seconds by 
inhalation of 100% Nitrogen gas. The signal generated by True Fisp sequence in the left 
ventricle lumen did not show any significant growth (APENDIX C), meaning that no 
semiquantitative measurements can be made with this sequence using such intrinsic 
contrast agent (time of 100% N2 = 25 seconds) 
 
Then, a change of the amount of nitrogen was performed. Since the signal obtained with 
25 seconds of 0% O2 and 100% N2 was not enough to produce a signal change useful for 
perfusion analysis, it was increased to 60 seconds.  
 
The results for this study are shown in Figure 40, on which we can observe that the signal 
change could be detected. Figure 41 shows the MRI signal scaled up to the values 
recorded by the pulse-oximeter. The minimum SpO2 achieved by the apnea induction 
was in the range of 30-35% with a duration of approximately 30 seconds. This value was 






5.3 Validation of the technique comparing both contrast agents: changes in FiO2 
and gadolinium-contrast image 
 
The validation of the new contrast agent was performed by comparing it with 
gadolinium results, both were post-processed using the same MATLAB software.  Signal 
Intensity-time curves from gadolinium reached values up to 5000-6000 (Figure 29), four 
times greater to what we have obtained with our new endogenous contrast agent 
(around 1100). However, the signal recorded by the MRI scanner is high enough to 
assess perfusion and all the drawbacks posed by gadolinium could be overcome with 
this innovative contrast.  
 
The semiquantitative measurement for myocardial based on the Gd curve slope ratio 
showed a value of 0.54 ± 0.04, very similar to the value obtain with the example of FiO2-





6. Limitations and future improvements  
 
Regarding image quality and resolution, it would be interesting to try new sequences or 
change parameters used for True Fisp. Some papers related to BOLD imaging suggest 
that FLASH sequence, a gradient echo sequence used for fast imaging acquisitions, is a 
good alternative for perfusions studies in the myocardium [38]. These improvements 
lead to an image of the heart where the anatomical structures are easily recognized by 
the physician. Other alternatives rely on image postprocessing, where a new software 
could be developed for the spatial co-registration of the heart. This would avoid 
inaccurate results derived from the respiratory motion. 
 
Since True Fisp does not offer any synchronization signal output during acquisition, it is 
of a great interest to find other alternatives for the synchronization of the MRI scanner 
with the gas mixer. This would reduce delay errors due to the contrast injection. There 
are several fast sequences that could be tested or either modify software given by the 
manufacturer so as to create the missing option. 
 
Finally, we have developed a Graphic User Interface for gadolinium-based contrast 
agent that generates the signal produced after a ROI is selected. It would be interesting 
to further improve such software including parametric maps of the myocardium. 
 
Besides all these improvements, an excellent way to demonstrate the feasibility of our 
approach would be the implementation in a pathological animal model. Currently there 
are animal models with cardiovascular disease that would directly affect myocardial 
perfusion. The comparison of healthy and pathological subjects could be the main goal 




7. Socio-economic impact and Regulatory Framework 
 




Among all the objectives of this project, the most important one relies on the social 
impact that these studies may have in the near future. For the moment this project is 
performed as a preclinical study, that is intended to understand all the results and 
mechanisms that will decide if the new method is ready for clinical research with 
humans. The proposed contras agent, changes in FiO2, is intended to offer a new 
alternative for the study of myocardial perfusion using the MRI as the acquisition 
technique.  
 
In addition, this new contrast agent will address the drawbacks and hazards offered by 
the Gadolinium. Patients with renal misfunction are not capable of completely filtering 
gadolinium out of their bodies causing nephrotoxicity with the risk of developing 
nephrogenic systemic fibrosis (NSF) [55]. In the same way, this type of contrast agent is 
contraindicated for pregnant woman, since the risks for the correct development of the 
fetus increase considerably with its use [56].  Most importantly, a paper highlighting the 
fact that gadolinium-based contrast agent may remain in the body as depositions in 
certain parts of the brain (nucleus and Globus pallidus) was published in 2014 by Kanda 





The Gadolinium contrast agent employed for the study marketed as ProHance 279.3 
mg/ml by an Italian multinational know as Bracco costs 280.89 euros for a bottle of 50 
ml. The proposed endogenous contrast agent produced with changes of FiO2 reduces 
greatly the costs incurred by the gadolinium. In addition, the costs of the injection 
procedure are removed since the new contrast agent is directly inhaled by the patient 
using the mouthpiece used for the anesthesia. 
 
7.2 Budget estimation 
 
The costs of this Thesis can be divided into: Materials, Services from the Gregorio 










MATERIAL cost/unit (€) quantity total cost (€) 
MATLAB  800 1 800 
Laptop 900 1 900 
RS-232-USB 15 2 30 
Gadolinium (prohance) 1 mL 5.6 1.5  8.4 




SERVICE cost/hour (€) time (hours) total cost (€) 
BRUKER MRI SCANNER 91 12 1092 
TECHNICIAN 17 12  204 
ANESTHESIA 10 12  120 




HUMAN RESOURCES cost/hour (€) time (hours) total cost (€) 
BIOMEDICAL ENGINEER 15 600 9000 
Supervisor 33 170 5610 




COST SOURCE cost (€) iva (21%) final cost (€) 
materials 1738.4  1738.4 
services 1416 297.36 1713.36 
human resources 14610  14610 
  TOTAL 18061.76 
 
7.3 Regulatory Framework 
 
The entire project was performed using small laboratory animals. Therefore, different 
ethics and regulatory concerns involving the usage of this model must be taken into 
account throughout the experimental procedures. All parts of the study involving these 
animals were performed according to the National regulation (RD 53/2013 and Orden 
ECC 566/2015) and EU regulation (2010/63/EU) [58]–[60].  
 
Furthermore, every research protocol and procedure that implies laboratory animals in 
the center, must be approved by the Comité de Ética de Experimentación Animal (CEEA) 




8. Final Conclusion 
 
After all the work performed in this project it can be conclude that all its objectives were 
achieve with highly positive results. The implementation of the first-pass perfusion of 
the myocardium using gadolinium as contrast agent was well assessed since the signal 
change was fully recorded by the MRI scanner and its completely ready to be tested with 
animal models suffering from ischemic diseases. For such protocol, a GUI was developed 
using MATLAB code allowing the physician to visualize the resulting signal in a less 
complicated way. This can be used as a diagnostic tool. 
 
Apart from gadolinium, we were able to use FiO2 as an endogenous contrast agent by 
proving how the scanner is capable of recording changes in FiO2 as a signal in the heart’s 
myocardium and lumen. The signal is not as precise and accurate as the one produced 
by gadolinium, but it can be furtherly improved in the future so as to be able to translate 
this type of experiments to humans. This innovative contrast agent is a focal point for 
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First image represents our template image chosen from the original data. Image on the 
upper right corner includes the myocardium ROI (in red) selected by the user. The ROI 
selected is based on the first image and will be used for the mask. Third image represents 
the mask created with the ROI selection composed by 1s and 0s. Our ROI is filled with 
1s and the rest of the image will be considered to be 0s. This mask is now multiplied by 
all the images of our study, therefore from now on we will only take into account the 
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Points selected for the myocardium slope. Points selected for the Left Ventricle slope. 
 
 





































Signal Intensity-time curve of the Left Ventricle 
 
 
